Know How Nexletol Stacks Up to Other Non-Statins

You’ll hear buzz about Nexletol (NEKS-leh-tol, bempedoic acid), a new oral non-statin cholesterol med.

Nexletol is the first ATP-citrate lyase inhibitor...blocking an earlier step of cholesterol synthesis in the liver than statins.

It’s approved for patients with familial hypercholesterolemia or CV disease who need more LDL lowering...despite max tolerated statins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote